NSE · AJOONI

Ajooni Biotech Limited

Sector: Healthcare · ISIN: INE820Y01021

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,381

of 5,072 stocks

▼ 361W

Peak #3,345 · 21 Sep 2026

Operating in Healthcare, Ajooni Biotech Limited is growing revenue rapidly, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 27%. Ownership as of Jun 2026.

Market Cap

54.95 Cr

P/E Ratio

12.76

P/B Ratio

0.60

ROE

4.74%

ROCE

6.95%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	63.49 Cr	60.62 Cr	58.75 Cr	31.74 Cr
Net Profit	43.18 L	94.72 L	1.65 Cr	93.21 L
EPS	0.01	0.05	0.10	0.08
Operating Profit	1.14 Cr	1.41 Cr	2.54 Cr	1.41 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

26.89%

Public

73.11%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
10 Sep 2024	Other	Annual General Meeting
07 May 2024	Rights	Rights 1:1 @ Premium Rs 3/-
29 Aug 2023	Other	Annual General Meeting
25 Nov 2022	Rights	Rights 29:30 @ Premium Rs 4/-
07 Oct 2022	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs